PERLETTI, G. Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer. Archivio Italiano di Urologia e Andrologia, [S. l.], v. 88, n. 1, p. 74–75, 2016. DOI: 10.4081/aiua.2016.1.74. Disponível em: https://www.pagepressjournals.org/aiua/article/view/aiua.2016.1.74. Acesso em: 19 apr. 2024.